Dog Heartworm Prevention in High-Risk Regions

Heartworm disease prevention requires consistent year-round prophylaxis in endemic regions, with lapsed prevention creating high-risk windows that lead to this serious and welfare-costly condition.

Key Facts

Heartworm season extends year-round in warm climates and seasonally in temperate regions where preventive timing matters
Preventive medications including ivermectin, milbemycin and moxidectin are highly effective when given consistently
Annual testing is recommended even for dogs on continuous prevention — to detect any treatment gaps or rare breakthrough infections
Import of dogs from endemic regions into non-endemic areas requires testing and quarantine protocols
Treatment of established heartworm infection requires months of strict exercise restriction causing welfare compromise
Microfilariae in the bloodstream of infected dogs are transmitted by mosquitoes to other dogs

Welfare Considerations

Heartworm prevention is one of the most straightforward welfare interventions available to dog owners in endemic regions. The comparison is stark: monthly administration of an inexpensive preventive medication versus months of exercise restriction and expensive, welfare-costly treatment for established infection. The welfare case for consistent prevention is overwhelming. Community-level prevention access programmes that provide affordable monthly preventives to lower-income households extend this benefit to dogs whose owners cannot afford commercial prevention costs.

What You Can Do

Administer year-round heartworm prevention consistently without gaps in endemic regions
Test annually even on prevention — to detect any resistance or compliance gaps
Test rescue dogs from endemic regions before beginning prevention protocols
Donate to community prevention access programmes in endemic areas
Advocate for subsidised prevention access for dog owners who cannot afford commercial products